CD22low/Bcl-2high expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia
Titel:
CD22low/Bcl-2high expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia
Auteur:
Wintering, Astrid Ishiyama, Kenichi Tamaki, Stanley Tamaki, Courtney Fandel, Joshua Ji, Lingyun Wood, Brent L. Shah, Nirali N. Yuan, Constance M. O’Brien, Maureen M. Loh, Mignon L. Diaz-Flores, Ernesto